Astherna is a new member of HollandBIO
23 August 2023
HollandBIO is the Dutch biotech industry association connecting, supporting, and representing over 275 medical, agro-food,…
New investment in our company!
14 July 2023
The Astherna team is happy to announce the recent new investment in our company by…
When your world turns dark
10 July 2023
In the current online available Pulse Magazine, there is an interesting article titled "Two Sides…
Collaborating with the FDA on developing treatments for Inherited Retinal Diseases.
10 June 2023
Last June 8th, our co-founder Pr. Dr. Carel Hoyng attended to an important meeting with…
Rob Collin gave a talk during the DCRT (Dutch center for RNA therapeutics) session at the 2nd Dutch Antisense Therapeutics Symposium (DATS) (1st-2nd June).
5 June 2023
The past 1st and 2nd of June, the second Dutch Antisense Therapeutics Symposium (DATS) took…
Astherna is introduced to Minister Kuipers
12 May 2023
Earlier on 10th May, Rob had the honour of presenting our work to the Minister…